| 产品详情 |
| Edit |   |
|---|
| Product Name | LY2157299 |
|---|
| Description | LY2157299 is a TGF-β type I receptor kinase inhibitor. LY2157299 has been used to inhance chemotherapy action against triple negative breast cancer (TNBC). Molecular Formula: C22H19N5O Solubility: DMSO (Slightly), Methanol (Slightly) Molecular Weight: 369.42 |
|---|
| Size | 5mg, 10mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 454031 |
|---|
| Price | |
|---|
| Order / More Info | LY2157299 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|